TABLE 2.
Outcomes | Patients with LDL-C < 100 mg per dL | Patients with LDL-C ≥ 100 mg per dL | P Value |
---|---|---|---|
Number | 59,184 | 30,083 | – |
LDL-C, mg per dL, mean (SD) | 71.9 (17.5) | 128.7 (27.7) | < 0.001 |
FRSCVDa | |||
Mean (SD) | 0.2226 (0.1633) | 0.2278 (0.1724) | 0.097 |
Missing | 50,023 | 25,929 | – |
Potential LDL-C reduction, mg per dL, mean (SD) | – | 28.7 (27.7) | – |
Potential reduction in relative risk of CVD, % | – | 14.8 | – |
Potential absolute reduction in 10-year CVD risk, % | – | 3.9 | – |
aBased on the 4,154 patients with FRSCVD values.
CVD = cardiovascular disease; FRSCVD = Framingham Risk Score for cardiovascular disease; LDL-C = low-density lipoprotein cholesterol; SD = standard deviation.